Health News

Pfizer studying coronavirus oral antibody therapeutic

Fox News Flash top headlines for March 23 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. Pfizer has begun a U.S.-based clinical trial examining the safety and tolerability of an oral antiviral therapeutic against the virus causing COVID-19 disease, the company announced Tuesday. The so-called “protease inhibitor” candidate works by […]

Health News

Link between driver of ovarian cancer and metabolism opens up new therapeutic strategies

Mutations that inactivate the ARID1A gene in ovarian cancer increase utilization of the glutamine amino acid making cancer cells dependent on glutamine metabolism, according to a study by The Wistar Institute published online in Nature Cancer. Researchers also showed that pharmacologic inhibition of glutamine metabolism may represent an effective therapeutic strategy for ARID1A-mutant ovarian cancer. […]

Health News

Novel therapeutic targets ulcerative colitis

Biologics to modulate the migration and activation of specific innate immune cells, called neutrophils, discovered in the lab of Beth McCormick, Ph.D., at UMass Medical School, have been licensed by Bacainn Therapeutics, Inc., to develop treatments for various acute medical conditions, including ulcerative colitis. The Massachusetts company received FDA clearance for a Phase I clinical […]

Health News

Researchers pinpoint potential new therapeutic target for eye disease

Multi-disciplinary work led by researchers from Trinity has pinpointed a potential new therapeutic target for treating retinal degeneration. The researchers have discovered that a protein (SARM1) involved in neuronal cell injury may also have a role in the progression of retinal degeneration. The research, involving experts from Trinity’s Schools of Medicine, Biochemisty and Immunology, Genetics […]

Health News

Novel therapeutic targets in cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma (cuSCC) is the second most common diagnosed malignancy in the United States, with approximately 700,000 new cases each year. Cumulative exposure to ultraviolet light is the primary environmental risk factor that leads to cuSCC. While the majority of cuSCC cases are easily managed and treated, a small percentage of patients do […]